Evidence map›Paper›PMID 40874606›Full record

ArticlemSphere2025

Potential for prolonged replication of common acute respiratory viruses in air-liquid interface cultures of primary human airway cells.

Miyuki Kawase, Reiko Suwa, Satoko Sugimoto, Masatoshi Kakizaki, Yohei Kume, Hisao Okabe, Sakurako Norito, Makoto Ujike, Hayato Go, Mitsuaki Hosoya and 2 more

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Miyuki KawaseDepartment of Virology III, National Institute of Infectious Disease, Musashimurayama, Tokyo, Japan.
Reiko SuwaDepartment of Virology III, National Institute of Infectious Disease, Musashimurayama, Tokyo, Japan.
Satoko SugimotoDepartment of Virology III, National Institute of Infectious Disease, Musashimurayama, Tokyo, Japan.
Masatoshi KakizakiDepartment of Virology III, National Institute of Infectious Disease, Musashimurayama, Tokyo, Japan.
Yohei KumeDepartment of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Fukushima, Japan.
Hisao OkabeDepartment of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Fukushima, Japan.
Sakurako NoritoDepartment of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Fukushima, Japan.
Makoto UjikeFaculty of Veterinary Medicine, Nippon Veterinary and Life Science University, Musashino, Tokyo, Japan.ORCID 0000-0002-7145-7126
Hayato GoDepartment of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Fukushima, Japan.
Mitsuaki HosoyaDepartment of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Fukushima, Japan.
Koichi HashimotoDepartment of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Fukushima, Japan.ORCID 0000-0003-4955-6221
Kazuya ShiratoDepartment of Virology III, National Institute of Infectious Disease, Musashimurayama, Tokyo, Japan.ORCID 0000-0002-3375-9799

Funding

Japan Agency for Medical Research and Development JP22fk0108119Japan Agency for Medical Research and Development JP22fk0108543Japan Agency for Medical Research and Development JP23fk0108661Kawano Masanori Memorial Public Interest Incorporated Foundation 35-15
6 · The paper itself

Abstract

A previous study provides clinical evidence that extended respiratory virus detection can occur in healthy pediatric individuals. However, it remains unclear how long respiratory viruses can survive in the human respiratory tissue. In this study, the replication potential of common respiratory viruses was evaluated using air-liquid interface (ALI) cultures of primary human respiratory epithelial cells. The findings demonstrate that most respiratory viruses can replicate for approximately 100 days in ALI cultures, with some showing prolonged replication for up to 150-200 days. In contrast, influenza and respiratory DNA viruses showed shorter replication periods likely due to virus-induced cell death. Even during the late phase, some samples continued to support viral replication in re-infection experiments, indicating sustained viral viability. ALI cultures, which lack effector immune cells, did not exhibit apparent type I interferon responses during long-term replication, except for transient IFNβ secretion in the early phase of infection, suggesting a state of tolerance that allows prolonged viral replication. Furthermore, genetic analysis revealed that viruses replicating for more than 50-60 days developed genetic variations, indicating an increased risk of mutations during prolonged infection. These results suggest that common respiratory viruses can remain detectable in human respiratory tissues for extended periods. However, transmission within 50-60 days may be preferable to reduce the risk of generating genetic variants. This concern is particularly relevant in immunocompromised individuals, where prolonged infections may facilitate viral evolution and contribute to the emergence of novel variants. IMPORTANCE: This study demonstrates that most common respiratory viruses, excluding influenza and DNA viruses, can replicate and produce infectious progeny for an average of up to 100 days in air-liquid interface (ALI) cultures of primary human respiratory epithelial cells without obvious innate immune responses. These findings imply that extended viral replication may occur in human hosts, potentially supported by the slow turnover of the respiratory epithelium. Notably, replication beyond 50-60 days was associated with the accumulation of genetic variations, suggesting a potential mechanism for the emergence of novel variants. To mitigate this risk, limiting transmission to within 50-60 days may be preferable. This issue is particularly relevant in immunocompromised individuals, where prolonged infection may promote viral evolution. Together, these findings provide insight into the replication dynamics of respiratory viruses in human tissue and highlight the importance of limiting long-term replication to prevent the emergence of new variants.

Indexed as

Epithelial CellsRespiratory MucosaVirusesVirus ReplicationCells, CulturedHumansTime FactorsHBTEC-ALIHNEpC-ALIreplicationrespiratory viruses

Identifiers

PMID40874606
PMCPMC12482148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.